Natural killer deficiency: A minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis?

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 9, 2003, Pages 680-683

  Schneider, E Marion ^a   Lorenz, Ingrid ^a   Walther, Paul ^a   Janka Schaub, Gritta E ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL; DISEASE ASSOCIATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HERPES VIRUS INFECTION; HISTIOCYTOSIS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MUTATION; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL;

ANTIGEN-PRESENTING CELLS; CHILD, PRESCHOOL; HERPESVIRIDAE INFECTIONS; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; KILLER CELLS, NATURAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0043236325     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200309000-00002     Document Type: Note

References (30)

1. Schneider EM, Lorenz I, Muller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood. 2002;100:2891-2898.
2. Egeler RM, Shapiro R, Loechelt B, et al. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 1996;18:340-345.
3. Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590-597.
4. Clementi R, zur Stadt U, Savoldi G, et al. Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. J Med Genet. 2001;38:643-646.
5. Jawahar S, Moody C, Chan M, et al. Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CDI6-II). Clin Exp Immunol. 1996;103:408-413.
6. Orange JS, Fassett MS, Koopman LA, et al. Viral evasion of natural killer cells. Nat Immunol. 2002;3:1006-1012.
7. Jahng AW, Maricic I, Pedersen B, et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med. 2001;194:1789-1799.
8. Betten A, Dahlgren C, Hermodsson S, et al. Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol. 2001;70:65-72.
9. Poggi A, Costa P, Tomasello E, et al. IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur J Immunol. 1998;28:1611-1616.
10. Ito M, Watanabe M, Kamiya H, et al. Inhibition of natural killer cell activity against cytomegalovirus-infected fibroblasts by nitric oxide-releasing agents. Cell Immunol. 1996;174:13-18.
11. Norris S, Doherty DG, Curry M, et al. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol Immunother. 2003;52:53-58.
12. Dufourcq-Lagelouse R, Pastural E, Barrat FJ, et al. Genetic basis of hemophagocytic lymphohistiocytosis syndrome. Int J Mol Med. 1999;4:127-133.
13. Stepp SE, Mathew PA, Bennett M, et al. Perforin: more than just an effector molecule. Immunol Today. 2000;21:254-256.
14. Suga N, Takada H, Nomura A, et al. Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. Br J Haematol. 2002;116:346-349.
15. Metkar SS, Wang B, Aguilar-Santelises M, et al. Cytotoxic cell granule-mediated apoptosis: perform delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity. 2002;16:417-428.
16. Fadeel B, Orrenius S, Henter JI. Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. Br J Haematol. 1999;106:406-415.
17. Schneider EM, Menzl I, Weber O, et al. Differential calcium response in HeLa and HeLa-Fas cells by cytotoxic T lymphocytes. Biochem Biophys Res Commun. 2003;301:159-166.
18. Wilson JL, Heffler LC, Charo J, et al. Targeting of human dendritic cells by autologous NK cells. J Immunol. 1999;163:6365-6370.
19. Piccioli D, Sbrana S, Melandri E, et al. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med. 2002;195:335-341.
20. Fernandez NC, Flament C, Crepineau F, et al. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur Cytokine Netw. 2002;13:17-27.
21. Racke FK, Clare-Salzer M, Wilson SB. Control of myeloid dendritic cell differentiation and function by CD1d-restricted (NK) T cells. Front Biosci. 2002:7:d978-d985.
22. Yu Y, Hagihara M, Ando K, et al. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol. 2001;166:1590-1600.
23. Halary F, Amara A, Lortat-Jacob H, et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity. 2002;17:653-664.
24. Lore K, Sonnerborg A, Brostrom C, et al. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS. 2002;16:683-692.
25. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259-272.
26. Takayama T, Morelli AE, Onai N, et al. Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J Immunol. 2001;166:7136-7143.
27. Buonocore S, Van Meirvenne S, Demoor FX, et al. Dendritic cells transduced with viral interleukin 10 or Fas ligand: no evidence for induction of allotolerance in vivo. Transplantation. 2002;73:S27-S30.
28. Sullivan KE, Delaat CA, Douglas SD, et al. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res. 1998;44:465-468.
29. Lacorazza HD, Miyazaki Y, Di Cristofano A, et al. The ETS protein MEF plays a critical role in perform gene expression and the development of natural killer and NK-T cells. Immunity. 2002;17:437-449.
30. Ferlazzo G, Tsang ML, Moretta L, et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195:343-351.